These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9078531)

  • 1. Alternative pathway activation of the complement system in preterm infants with early onset infection.
    Zilow EP; Hauck W; Linderkamp O; Zilow G
    Pediatr Res; 1997 Mar; 41(3):334-9. PubMed ID: 9078531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation in newborn infants with early onset infection.
    Zilow G; Zilow EP; Burger R; Linderkamp O
    Pediatr Res; 1993 Aug; 34(2):199-203. PubMed ID: 8233725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of the complement activation product SC5 b-9 is applicable in neonates in spite of their profound C9 deficiency.
    Høgåsen AK; Overlie I; Hansen TW; Abrahamsen TG; Finne PH; Høgåsen K
    J Perinat Med; 2000; 28(1):39-48. PubMed ID: 10765513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
    Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation in platelet concentrates is surface-dependent and modulated by the platelets.
    Gyongyossy-Issa MI; McLeod E; Devine DV
    J Lab Clin Med; 1994 Jun; 123(6):859-68. PubMed ID: 8201264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in prestorage leucocyte-filtered plasma.
    Hyllner M; Tylman M; Bengtson JP; Rydberg L; Bengtsson A
    Transfus Med; 2004 Feb; 14(1):45-52. PubMed ID: 15043593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide binding protein in preterm infants.
    Behrendt D; Dembinski J; Heep A; Bartmann P
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F551-4. PubMed ID: 15499153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement profile in neonates of different gestational ages.
    Grumach AS; Ceccon ME; Rutz R; Fertig A; Kirschfink M
    Scand J Immunol; 2014 Apr; 79(4):276-81. PubMed ID: 24460650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activation products in liquid stored plasma and C3a kinetics after transfusion of autologous plasma.
    Norda R; Schött U; Berséus O; Akerblom O; Nilsson B; Ekdahl KN; Stegmayr BG; Knutson F
    Vox Sang; 2012 Feb; 102(2):125-33. PubMed ID: 21770955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
    Hamad I; Hunter AC; Szebeni J; Moghimi SM
    Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin levels of thrombocytopenic term and preterm newborns with infection.
    Oygür N; Tunga M; Mumcu Y; Yeşilipek A; Güra A; Coşkun M; Yeğin O
    Am J Perinatol; 2001 Aug; 18(5):279-86. PubMed ID: 11552180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
    Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
    Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the alternative pathway in the early complement activation following major trauma.
    Ganter MT; Brohi K; Cohen MJ; Shaffer LA; Walsh MC; Stahl GL; Pittet JF
    Shock; 2007 Jul; 28(1):29-34. PubMed ID: 17510601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of terminal SC5b-9 complement complexes: a new index of blood-membrane interaction.
    Schaefer RM; Rauterberg EW; Deppisch R; Vienken J
    Miner Electrolyte Metab; 1990; 16(1):73-6. PubMed ID: 2325595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significance of C-reactive proteins (CRP) in serum in bacterial infections of premature infants].
    Künzer W; Uhlig T
    Monatsschr Kinderheilkd; 1983 Sep; 131(9):573-6. PubMed ID: 6413842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement and contact activation related to surfactant response in respiratory distress syndrome.
    Wagner MH; Sonntag J; Strauss E; Obladen M
    Pediatr Res; 1999 Jan; 45(1):14-8. PubMed ID: 9890603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two factors of the lectin pathway of complement, l-ficolin and mannan-binding lectin, and their associations with prematurity, low birthweight and infections in a large cohort of Polish neonates.
    Swierzko AS; Atkinson AP; Cedzynski M; Macdonald SL; Szala A; Domzalska-Popadiuk I; Borkowska-Klos M; Jopek A; Szczapa J; Matsushita M; Szemraj J; Turner ML; Kilpatrick DC
    Mol Immunol; 2009 Feb; 46(4):551-8. PubMed ID: 18950864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in diabetic ketoacidosis and its treatment.
    Jerath RS; Burek CL; Hoffman WH; Passmore GG
    Clin Immunol; 2005 Jul; 116(1):11-7. PubMed ID: 15925827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.